Skip to product information
1 of 1

BT Lab

SKU:BT-AP02748

Duffy Polyclonal Antibody

Duffy Polyclonal Antibody

Regular price $275.00 USD
Regular price Sale price $275.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

The atypical chemokine receptor 1 (Duffy blood group) encoded by ACKR1 is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene.

The Duffy Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of Duffy antigen receptor for chemokines (DARC) expression. This antibody is produced using state-of-the-art techniques, ensuring high affinity and sensitivity. It has been extensively validated for various applications, including immunohistochemistry, western blotting, and flow cytometry.

The Duffy Polyclonal Antibody exhibits exceptional performance in detecting DARC expression in a wide range of tissues and cell types. Its superior specificity allows for accurate and precise identification of DARC-positive cells, enabling researchers to gain valuable insights into the role of DARC in various physiological and pathological processes.

This antibody is manufactured under stringent quality control measures to ensure batch-to-batch consistency and reproducibility. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation. The Duffy Polyclonal Antibody is compatible with various detection systems and can be used in combination with other antibodies for multiplex staining experiments.

With its exceptional performance, reliability, and versatility, the Duffy Polyclonal Antibody is an indispensable tool for researchers studying DARC expression and its implications in various fields, including immunology, oncology, and cardiovascular research.

View full details